LKFT Stock Price, Chart, Stats & News

Lakefront Biotherapeutics N.V.
Save
Lakefront Biotherapeutics N.V. (LKFT) does not currently pay a dividend.
1.88B
Market cap
2.68x
Current P/E
344.83x
Forward P/E
LKFT chart
1M
3M
1Y
5Y
Loading chart...
About
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.
Similar securities
Based on sector and market capitalization
Report issue





